bnt211
biontech
['bnt211']
bnt211, a combination car t-cell receptor and car t-cell-amplifying rna vaccine (carvac) therapy, has demonstrated a manageable safety profile with promising signs of clinical activity in patients with cldn6-positive testicular cancer. #esmo22 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.